Correlation Between Alpha Tau and Syros Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alpha Tau and Syros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alpha Tau and Syros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alpha Tau Medical and Syros Pharmaceuticals, you can compare the effects of market volatilities on Alpha Tau and Syros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alpha Tau with a short position of Syros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alpha Tau and Syros Pharmaceuticals.

Diversification Opportunities for Alpha Tau and Syros Pharmaceuticals

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Alpha and Syros is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Alpha Tau Medical and Syros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syros Pharmaceuticals and Alpha Tau is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alpha Tau Medical are associated (or correlated) with Syros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syros Pharmaceuticals has no effect on the direction of Alpha Tau i.e., Alpha Tau and Syros Pharmaceuticals go up and down completely randomly.

Pair Corralation between Alpha Tau and Syros Pharmaceuticals

Given the investment horizon of 90 days Alpha Tau Medical is expected to generate 0.21 times more return on investment than Syros Pharmaceuticals. However, Alpha Tau Medical is 4.71 times less risky than Syros Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Syros Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest  240.00  in Alpha Tau Medical on September 12, 2024 and sell it today you would earn a total of  67.00  from holding Alpha Tau Medical or generate 27.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Alpha Tau Medical  vs.  Syros Pharmaceuticals

 Performance 
       Timeline  
Alpha Tau Medical 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Alpha Tau Medical are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Alpha Tau unveiled solid returns over the last few months and may actually be approaching a breakup point.
Syros Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Syros Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Alpha Tau and Syros Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alpha Tau and Syros Pharmaceuticals

The main advantage of trading using opposite Alpha Tau and Syros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alpha Tau position performs unexpectedly, Syros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syros Pharmaceuticals will offset losses from the drop in Syros Pharmaceuticals' long position.
The idea behind Alpha Tau Medical and Syros Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Bonds Directory
Find actively traded corporate debentures issued by US companies